超声诊断原发性肝细胞癌右房转移1例

2020-03-08 周秘 谭静 尹立雪 临床超声医学杂志

患者女,53岁,丙肝抗体阳性20余年,未监测肝功能和甲胎蛋白,未进行影像学评估。1年前因腹痛1周入院,经腹超声检查:右肝见一大小为8.7 cm×6.3 cm的团状稍低回声,内部回声不均匀,

患者女,53岁,丙肝抗体阳性20余年,未监测肝功能和甲胎蛋白,未进行影像学评估。1年前因腹痛1周入院,经腹超声检查:右肝见一大小为8.7 cm×6.3 cm的团状稍低回声,内部回声不均匀,边界不清(图1),经肘静脉团注造影剂后,团块动脉相呈快速高增强,门脉相和延迟相呈低增强(图2),超声诊断:右肝富血供肿瘤性改变。
 
图1 右肝见团状稍低回声,内部回声不均匀(箭头示)
 
图2 经肘静脉团注造影剂后,团块动脉相呈快速高增强(箭头示)
 
增强CT示:肝右叶团片状稍低密度影,门静脉宽约1.3 cm,未见充盈缺损征象。超声心动图未见明显异常。实验室检查:甲胎蛋白247.40 ng/ml,D-二聚体2.29 μg/ml,纤维蛋白/纤维蛋白降解产物7.1 μg/L,血浆凝血酶原时间16.1 s,血浆凝血酶原国际标准化比率1.36。给予肝动脉化疗灌注栓塞术治疗后出院。
 
3个月后患者因胸闷行超声心动图检查:右房侧壁见一大小约2.5 cm×1.9 cm的团状稍低回声,不随心脏搏动而运动,房间隔中份纤细并凸向左房(图3);下腔静脉内见团状低回声延续至右房与右房内团状低回声相连,其与下腔静脉粘连紧密,活动度小(图4)。超声诊断:右房内实质性占位(考虑转移瘤);房间隔膨胀瘤。
 
图3 右房侧壁见团状稍低回声(箭头示房间隔膨胀瘤),不随心脏搏动而运动(RA:右房;LA:左房;RV:右室)
 
图4 下腔静脉内见团状低回声延续至右房(箭头示)并与右房内团状低回声相连(RA:右房;LA:左房;RV:右室;IVC:下腔静脉)
 
讨论:
 
肝细胞肝癌(hepatocellular carcinoma,HCC)的早期发现、诊断及规范化监测可极大地改善患者的生存质量和预后结果。本例患者发现丙肝抗体阳性,为HCC 高风险人群,但未规范化监测腹部超声和甲胎蛋白水平,导致疾病发现时已处于晚期。本例患者甲胎蛋白水平明显增高,超声造影表现为动脉相高增强,门脉相和延迟相呈低增强的典型HCC 特征。
 
超声心动图是早期诊断心脏转移肿瘤较好的影像学方法,但发现时原发肿瘤多处于疾病晚期。本例右房内占位应与血栓感染性赘生物鉴别诊断。心脏肿瘤无其他器官受累时应彻底手术切除以解除梗阻症状,但手术仅切除心脏内肿瘤患者的术后生存时间较短,平均为6 个月。本例患者未接受进一步活检及手术治疗,并自动出院,故在短期内死亡。本病例提示原发性肝细胞肝癌患者可能发生心脏转移,对于该类患者尽管无心脏相关症状也应行常规超声心动图筛查,以提高临床诊断准确率。
 
原始出处:
 
周秘,谭静,尹立雪,张文军,兰海,胥卉苹,许达,刘蓉.超声诊断原发性肝细胞肝癌右房转移1例[J].临床超声医学杂志,2019,21(01):16.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1978950, encodeId=95f119e895002, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sat Aug 01 22:05:33 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863476, encodeId=2dc618634e6df, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Wed Jul 01 17:05:33 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846867, encodeId=40ce184686e3d, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Nov 12 12:05:33 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989749, encodeId=321f1989e491e, content=<a href='/topic/show?id=91583e09134' target=_blank style='color:#2F92EE;'>#原发性肝细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37091, encryptionId=91583e09134, topicName=原发性肝细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Fri Jun 05 00:05:33 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560017, encodeId=e0c0156001e99, content=<a href='/topic/show?id=c1eb9282699' target=_blank style='color:#2F92EE;'>#超声诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92826, encryptionId=c1eb9282699, topicName=超声诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebf15056071, createdName=tcm104hq, createdTime=Tue Mar 10 08:05:33 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566026, encodeId=38e21566026ce, content=<a href='/topic/show?id=c1eb9282699' target=_blank style='color:#2F92EE;'>#超声诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92826, encryptionId=c1eb9282699, topicName=超声诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebf15056071, createdName=tcm104hq, createdTime=Tue Mar 10 08:05:33 CST 2020, time=2020-03-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1978950, encodeId=95f119e895002, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sat Aug 01 22:05:33 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863476, encodeId=2dc618634e6df, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Wed Jul 01 17:05:33 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846867, encodeId=40ce184686e3d, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Nov 12 12:05:33 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989749, encodeId=321f1989e491e, content=<a href='/topic/show?id=91583e09134' target=_blank style='color:#2F92EE;'>#原发性肝细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37091, encryptionId=91583e09134, topicName=原发性肝细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Fri Jun 05 00:05:33 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560017, encodeId=e0c0156001e99, content=<a href='/topic/show?id=c1eb9282699' target=_blank style='color:#2F92EE;'>#超声诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92826, encryptionId=c1eb9282699, topicName=超声诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebf15056071, createdName=tcm104hq, createdTime=Tue Mar 10 08:05:33 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566026, encodeId=38e21566026ce, content=<a href='/topic/show?id=c1eb9282699' target=_blank style='color:#2F92EE;'>#超声诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92826, encryptionId=c1eb9282699, topicName=超声诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebf15056071, createdName=tcm104hq, createdTime=Tue Mar 10 08:05:33 CST 2020, time=2020-03-10, status=1, ipAttribution=)]
    2020-07-01 xjy02
  3. [GetPortalCommentsPageByObjectIdResponse(id=1978950, encodeId=95f119e895002, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sat Aug 01 22:05:33 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863476, encodeId=2dc618634e6df, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Wed Jul 01 17:05:33 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846867, encodeId=40ce184686e3d, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Nov 12 12:05:33 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989749, encodeId=321f1989e491e, content=<a href='/topic/show?id=91583e09134' target=_blank style='color:#2F92EE;'>#原发性肝细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37091, encryptionId=91583e09134, topicName=原发性肝细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Fri Jun 05 00:05:33 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560017, encodeId=e0c0156001e99, content=<a href='/topic/show?id=c1eb9282699' target=_blank style='color:#2F92EE;'>#超声诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92826, encryptionId=c1eb9282699, topicName=超声诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebf15056071, createdName=tcm104hq, createdTime=Tue Mar 10 08:05:33 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566026, encodeId=38e21566026ce, content=<a href='/topic/show?id=c1eb9282699' target=_blank style='color:#2F92EE;'>#超声诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92826, encryptionId=c1eb9282699, topicName=超声诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebf15056071, createdName=tcm104hq, createdTime=Tue Mar 10 08:05:33 CST 2020, time=2020-03-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1978950, encodeId=95f119e895002, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sat Aug 01 22:05:33 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863476, encodeId=2dc618634e6df, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Wed Jul 01 17:05:33 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846867, encodeId=40ce184686e3d, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Nov 12 12:05:33 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989749, encodeId=321f1989e491e, content=<a href='/topic/show?id=91583e09134' target=_blank style='color:#2F92EE;'>#原发性肝细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37091, encryptionId=91583e09134, topicName=原发性肝细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Fri Jun 05 00:05:33 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560017, encodeId=e0c0156001e99, content=<a href='/topic/show?id=c1eb9282699' target=_blank style='color:#2F92EE;'>#超声诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92826, encryptionId=c1eb9282699, topicName=超声诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebf15056071, createdName=tcm104hq, createdTime=Tue Mar 10 08:05:33 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566026, encodeId=38e21566026ce, content=<a href='/topic/show?id=c1eb9282699' target=_blank style='color:#2F92EE;'>#超声诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92826, encryptionId=c1eb9282699, topicName=超声诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebf15056071, createdName=tcm104hq, createdTime=Tue Mar 10 08:05:33 CST 2020, time=2020-03-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1978950, encodeId=95f119e895002, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sat Aug 01 22:05:33 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863476, encodeId=2dc618634e6df, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Wed Jul 01 17:05:33 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846867, encodeId=40ce184686e3d, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Nov 12 12:05:33 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989749, encodeId=321f1989e491e, content=<a href='/topic/show?id=91583e09134' target=_blank style='color:#2F92EE;'>#原发性肝细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37091, encryptionId=91583e09134, topicName=原发性肝细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Fri Jun 05 00:05:33 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560017, encodeId=e0c0156001e99, content=<a href='/topic/show?id=c1eb9282699' target=_blank style='color:#2F92EE;'>#超声诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92826, encryptionId=c1eb9282699, topicName=超声诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebf15056071, createdName=tcm104hq, createdTime=Tue Mar 10 08:05:33 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566026, encodeId=38e21566026ce, content=<a href='/topic/show?id=c1eb9282699' target=_blank style='color:#2F92EE;'>#超声诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92826, encryptionId=c1eb9282699, topicName=超声诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebf15056071, createdName=tcm104hq, createdTime=Tue Mar 10 08:05:33 CST 2020, time=2020-03-10, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1978950, encodeId=95f119e895002, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Sat Aug 01 22:05:33 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863476, encodeId=2dc618634e6df, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Wed Jul 01 17:05:33 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846867, encodeId=40ce184686e3d, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Nov 12 12:05:33 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989749, encodeId=321f1989e491e, content=<a href='/topic/show?id=91583e09134' target=_blank style='color:#2F92EE;'>#原发性肝细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37091, encryptionId=91583e09134, topicName=原发性肝细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Fri Jun 05 00:05:33 CST 2020, time=2020-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560017, encodeId=e0c0156001e99, content=<a href='/topic/show?id=c1eb9282699' target=_blank style='color:#2F92EE;'>#超声诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92826, encryptionId=c1eb9282699, topicName=超声诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebf15056071, createdName=tcm104hq, createdTime=Tue Mar 10 08:05:33 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566026, encodeId=38e21566026ce, content=<a href='/topic/show?id=c1eb9282699' target=_blank style='color:#2F92EE;'>#超声诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92826, encryptionId=c1eb9282699, topicName=超声诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ebf15056071, createdName=tcm104hq, createdTime=Tue Mar 10 08:05:33 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

相关资讯

肝癌免疫治疗取得重大突破,患者总生存有望快速提升

2019年12月7日,第十七届全国肝癌学术会议今日于上海国际会议中心隆重召开,作为国内最高水准的肝癌专科学术会议,本届大会云集海内外肝癌领域临床及基础领域顶级专家学者,聚焦肝癌治疗规范化、个体化、综合诊疗理念,共同探讨肝癌诊疗新技术、新策略。大会期间,复旦大学附属中山医院携手肝癌患者组织,在罗氏制药支持下,共同发起提升中国肝癌患者长期生存的倡议,呼吁多方协作共同建立中国肝癌患者全病程管理体系,

国产肝癌创新药多纳非尼一线治疗晚期肝细胞癌III期临床研究获得成功

中国,昆山/上海;美国,加州:2020年01月01日,苏州泽璟生物制药股份有限公司(以下简称“泽璟制药”)今日宣布: ●多纳非尼一线治疗晚期肝细胞癌的III期注册临床研究达到了预设的主要研究终点和统计学要求; ●多纳非尼治疗组患者的总生存期与现有标准治疗索拉非尼对照组相比有显著延长,具有重要的科学意义和临床价值; ●多纳非尼治疗具有更好的安全性,患者耐受性良好。 甲苯磺酸多

Cell Death Differentiation:抑癌锌指同源盒2(ZHX2)在NAFLD发展成HCC的过程中的作用

非酒精性脂肪肝疾病(NAFLD)可导致肝细胞癌(简称肝癌HCC)。但其潜在机制目前仍不清楚。研究人员对抑癌锌指同源盒2(ZHX2)在NAFLD向HCC进展的过程中的作用进行研究。ZHX2的表达水平在脂肪肝组织中显著下降,特别是在患有NAFLD–HCC的肝脏中。ZHX2过表达则会扰乱培养的HCC细胞的脂质稳态,并能够抑制脂质在肝细胞中的沉积,无论是在体内还是体外。此外,ZHX2可通过转录抑制脂质脂肪

Cell Death Dis:CircRNA-5692可抑制肝细胞癌进展

环状RNA(circRNA)是一种非编码的RNA,可通过与miRNA和转录因子相互作用调节基因的表达。但目前仍不清楚哪种circRNA对于肝细胞癌(HCC)的发病至关重要。在本研究中,研究人员通过多种实验发现,circRNA-5692在肝癌组织中表达下调,而circRNA-5692过表达会减弱HCC细胞的恶性行为。生物信息学预测显示,circRNA-5692能够与miR-328-5p相互作用,而后

Brit J Cancer:较高的胆固醇水平与肝细胞癌的较低风险相关

该研究的结果表明他汀类药物对肝癌没有保护作用。

PD-1单抗单药治疗双原发癌,局部晚期肺鳞癌肿瘤疗效PR,肝细胞癌肿瘤疗效评估pCR

局部晚期肺鳞癌是一类相对难治性的疾病,驱动基因突变发生率低,既往主要治疗模式为化疗。免疫治疗的问世,为这类难治性患者带来了一种新的治疗手段和治疗新希望。目前,在我国,PD-1单抗联合化疗和PD-1单抗单药分别获批用于局部晚期肺鳞癌一线和二线治疗,且无论PD-L1的表达程度。以下分享一例二线入组信迪利单抗EAP项目的局部肺鳞癌合并原发性肝细胞癌的病例,该患者肺癌最佳疗效达部分缓解(PR),原发性肝细